Wei‐Ming Li

6.9k total citations · 1 hit paper
265 papers, 4.9k citations indexed

About

Wei‐Ming Li is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Ming Li has authored 265 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Surgery, 73 papers in Molecular Biology and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Ming Li's work include Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (28 papers) and Ferroptosis and cancer prognosis (21 papers). Wei‐Ming Li is often cited by papers focused on Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (28 papers) and Ferroptosis and cancer prognosis (21 papers). Wei‐Ming Li collaborates with scholars based in Taiwan, China and United States. Wei‐Ming Li's co-authors include Wen‐Jeng Wu, Hung‐Lung Ke, Hsin‐Chih Yeh, Chun‐Nung Huang, Ching‐Chia Li, Chien‐Feng Li, Yawei Xu, San‐Yuan Chen, Ching‐Chia Li and Chia‐Chu Liu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wei‐Ming Li

254 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In Vivo

2011 475 citations Wei‐Ming Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei‐Ming Li Taiwan	37	1.6k	1.1k	699	659	594	265	4.9k
Lianming Liao China	44	2.6k 1.7×	2.8k 2.6×	722 1.0×	1.0k 1.6×	862 1.5×	152	7.9k
Elena Bonanno Italy	39	1.7k 1.1×	714 0.7×	686 1.0×	907 1.4×	1.0k 1.7×	156	5.2k
Linda M. McManus United States	44	2.4k 1.5×	860 0.8×	426 0.6×	530 0.8×	565 1.0×	99	6.4k
Neal S. Fedarko United States	49	3.4k 2.2×	544 0.5×	552 0.8×	715 1.1×	1.4k 2.3×	108	8.2k
Liang Tang China	39	2.5k 1.6×	836 0.8×	410 0.6×	1.3k 2.0×	887 1.5×	220	6.0k
Augusto Orlandi Italy	50	2.6k 1.6×	1.8k 1.6×	953 1.4×	775 1.2×	1.2k 2.0×	306	8.7k
Melpo Christofidou‐Solomidou United States	45	2.1k 1.3×	353 0.3×	809 1.2×	624 0.9×	508 0.9×	110	5.3k
Zhongmin Liu China	50	2.9k 1.8×	955 0.9×	525 0.8×	935 1.4×	745 1.3×	235	7.1k
Guohui Liu China	43	2.6k 1.7×	1.1k 1.0×	235 0.3×	763 1.2×	641 1.1×	280	7.5k
Wen‐Jeng Wu Taiwan	38	1.7k 1.1×	1.7k 1.6×	1.6k 2.2×	676 1.0×	943 1.6×	397	5.7k

Countries citing papers authored by Wei‐Ming Li

Since Specialization

Citations

This map shows the geographic impact of Wei‐Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Li more than expected).

Fields of papers citing papers by Wei‐Ming Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Li. The network helps show where Wei‐Ming Li may publish in the future.

Co-authorship network of co-authors of Wei‐Ming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ming Li. A scholar is included among the top collaborators of Wei‐Ming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ming Li. Wei‐Ming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Ying, Chong‐Rui Xu, Dongyang Jiang, et al.. (2024). Protocol for tyramide signal amplification immunohistochemical detection of Notch1 signaling in the vascular system. STAR Protocols. 5(4). 103519–103519. 1 indexed citations

Li, Wei‐Ming, et al.. (2024). Hand-eye parameter estimation and line-structured light scanning calibration within a unified framework. Optics & Laser Technology. 183. 112323–112323.

Li, Kuibao, et al.. (2023). Nomograms Based on Non-High-Density Lipoprotein to Predict Outcomes in Patients with Prior Coronary Artery Bypass Grafting with Acute Coronary Syndrome: A Single-Center Retrospective Study. Therapeutics and Clinical Risk Management. Volume 19. 15–26. 1 indexed citations

Li, Wei‐Ming, Ti‐Chun Chan, Yu‐Ching Wei, et al.. (2023). Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis. Frontiers in Bioscience-Landmark. 28(9). 217–217. 2 indexed citations

Zhang, Shouhua, et al.. (2023). MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma. Pathology & Oncology Research. 29. 1610801–1610801. 6 indexed citations

Cheng, Fang, Qiling Xu, Qiang Li, et al.. (2023). Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies. Frontiers in Oncology. 13. 1113462–1113462. 16 indexed citations

Cheng, Fang, Guolin Yuan, Qiang Li, Zheng Cui, & Wei‐Ming Li. (2023). Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China. Frontiers in Oncology. 13. 1172910–1172910. 6 indexed citations

Lee, Yi‐Chen, Wei‐Ming Li, A‐Mei Huang, et al.. (2022). MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1. Cancers. 14(4). 880–880. 2 indexed citations

Chan, Ti‐Chun, Yi‐Ting Chen, Kien Thiam Tan, et al.. (2021). Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis. SHILAP Revista de lepidopterología. 11(12). e674–e674. 14 indexed citations

10.

Chien, Tsu‐Ming, Hsiang‐Ying Lee, Nirmish Singla, et al.. (2021). Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study. Cancers. 13(23). 5935–5935. 9 indexed citations

11.

Li, Ching‐Chia, Hung‐Lung Ke, Wei‐Ming Li, et al.. (2021). Low Hemoglobin-to-Red Cell Distribution Width Ratio Is Associated with Disease Progression and Poor Prognosis in Upper Tract Urothelial Carcinoma. Biomedicines. 9(6). 672–672. 22 indexed citations

12.

Lee, Hsiang‐Ying, Yen‐Hsu Chen, Wen‐Jeng Wu, et al.. (2020). The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database. International Journal of Clinical Oncology. 26(3). 569–577. 5 indexed citations

13.

Lee, Yi‐Chen, Peir‐In Liang, Lin‐Li Chang, et al.. (2019). CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas. Disease Markers. 2019. 1–9. 13 indexed citations

14.

Li, Chien‐Feng, Hung‐Lung Ke, Yow-Ling Shiue, et al.. (2018). High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas. Urologic Oncology Seminars and Original Investigations. 37(4). 293.e11–293.e24. 26 indexed citations

15.

Xue, Weili, Wei‐Ming Li, Yufeng Shang, et al.. (2018). One method to establish Epstein‐Barr virus‐associated NK/T cell lymphoma mouse models. Journal of Cellular and Molecular Medicine. 23(2). 1509–1516. 4 indexed citations

16.

Lee, Hsiang‐Ying, Ching‐Chia Li, Chun‐Nung Huang, et al.. (2014). INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. Journal of Surgical Oncology. 111(4). 414–422. 36 indexed citations

17.

Zhu, Xiaoming, Hongjiang Wang, Fan Liu, et al.. (2013). Identification of micro‐ RNA networks in end‐stage heart failure because of dilated cardiomyopathy. Journal of Cellular and Molecular Medicine. 17(9). 1173–1187. 32 indexed citations

18.

Lee, Yung‐Chin, Shu‐Pin Huang, Chia‐Chu Liu, et al.. (2012). The Association ofeNOSG894T Polymorphism with Metabolic Syndrome and Erectile Dysfunction. The Journal of Sexual Medicine. 9(3). 837–843. 28 indexed citations

19.

Hou, Lei, et al.. (2010). Comparative study on transradial versus transfemoral approach for primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction.. PubMed. 31(2). 158–62. 53 indexed citations

20.

Wei, Yidong, Kai Tang, Yanqing Chen, et al.. (2007). Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: a prospective, multi-center study. Chinese Medical Journal. 120(12). 1093–1096. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact